Dr. Sonpavde on Enfortumab Vedotin Data in Urothelial Cancer
October 9th 2019
Guru P. Sonpavde, MD, director, Bladder Cancer, and physician, Dana-Farber Cancer Institute, discusses the results of the phase II EV-201 trial in patients with locally advanced or metastatic urothelial cancer.